Background: Parkinson's disease (PD) has been hypothesized to be associated with certain personality traits, including conscientiousness and punctuality. However, research aimed at quantifying these traits is largely derived from questionnaire-based personality inventories rather than real-world observations.
Objective: To explore the presence of a parkinsonian personality profile by assessing the no-show rate of patients with PD versus other neurological disorders.
Methods: We extracted data from our electronic health record for all neurology appointments over a 78-month interval. Additionally, we obtained primary care appointment data for the same patients over the same timeframe. For each appointment we collected appointment date/time, check-in time, provider, age, sex, insurance type, days between appointment date and scheduling, diagnosis code, and no-show status.
Results: 19,433 unique patients (400 with PD) accounting for a total of 252,347 outpatient appointments were included in our analysis. The overall no-show rate for PD patients was 3% versus 7.4% for patients with other neurologic disorders (OND). No show rates for PD patients were lower than those with OND for both neurology appointments (2.7% versus 13.6%) and for primary care visits (3.1% versus 5.9%).
Conclusions: Patients with PD have lower no-show rates than patients with OND. Additionally, the no-show rate for patients with PD did not differ between their neurology and primary care appointments, confirming that patient's personality rather than provider traits account for this difference, and supporting the presence of a parkinsonian personality.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3233/JPD-191651 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An audit on the assessment and management of osteoporosis in a Parkinson's and related diseases clinic in Australia.
J Neurol
January 2025
Macquarie Medical School, Parkinson's Disease Research Clinic, Macquarie University, Sydney, NSW, 2109, Australia.
Background: Patients with Parkinson's disease (PD) and atypical parkinsonian syndromes are at increased risk of falls and should be actively screened and treated for osteoporosis. In 2024, the Royal Australian College of General Practitioners (RACGP) revised their practice guidelines for diagnosing and managing osteoporosis in postmenopausal women and men aged over 50 years.
Objective: We conducted the first Australian study to audit these guidelines in patients with PD and atypical parkinsonian syndromes.
Co-Expression of Tardive Dyskinesia and Drug-Induced Parkinsonism in Rats Chronically Treated With Haloperidol.
Neuropsychopharmacol Rep
March 2025
Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Aim: We aimed to create a rat model of drug-induced parkinsonism and tardive dyskinesia by chronic administration of haloperidol and examine the expression of direct and indirect pathway markers in the striatum of the model rats.
Methods: We treated 21 rats, 14 with haloperidol decanoate and 7 with placebo. The number of vacuous chewing movements per 2 min was counted, and haloperidol-treated rats were classified into two groups: mild and severe tardive dyskinesia.
Digital measurement of ocular microtremor in Parkinson's disease: Protocol for a pilot study to assess reliability and clinical validation.
PLoS One
January 2025
Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, United Kingdom.
Ocular microtremor (OMT) is a fixational eye movement that cannot be seen with the naked eye but is always present, even when the eye appears motionless/still. The link between OMT and brain function provides a strong rationale for investigation as there lies potential for its use as a biomarker in populations with neurological impairments. OMT frequency is typically 70-80Hz in healthy adults and research suggests that this will be reduced in those with neurological disease such as Parkinson's Disease (PD).
View Article and Find Full Text PDFParkinson's disease screening using a fusion of gait point cloud and silhouette features.
PLoS One
January 2025
Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Article Synopsis
- Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by slow movement, and while there is no cure, early detection can improve outcomes.
- Vision-based methods for PD detection focus on analyzing gait, utilizing both appearance-based and model-based approaches.
- A new method that combines these two approaches has shown promising results, achieving an AUC of 0.87 and F1-Scores of 0.82 in distinguishing between normal and Parkinsonian gait.
Characterizing pain in Parkinson's disease: types, predictors, and management implications.
Korean J Pain
January 2025
Department of Neurology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkiye.
Article Synopsis
- The study investigates the high prevalence of pain in Parkinson's disease (PD) patients, with 80.6% reporting pain, indicating its significant impact on quality of life.
- It distinguishes between neuropathic pain (NP) and musculoskeletal pain, finding that longer disease duration predicts NP and that females experience more musculoskeletal pain.
- The research highlights the correlation between anxiety and central parkinsonian pain and suggests further exploration of amantadine's potential benefits in managing pain, emphasizing the need for personalized treatment approaches in PD.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!